KELLEY YOUNG: Open Payments
NPI 1346413309 · RAVENNA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 35 payments from 9 companies in 2025. Trend: 2023 $129 · 2024 $487 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $150 |
| AstraZeneca Pharmaceuticals LP | 7 | $130 |
| Lilly USA, LLC | 7 | $120 |
| GlaxoSmithKline, LLC. | 6 | $112 |
| ABBVIE INC. | 3 | $73 |
| PFIZER INC. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: TRELEGY ELLIPTA, Ozempic, MOUNJARO, AIRSUPRA, BREZTRI, QULIPTA, AJOVY, VRAYLAR.
Industry payments across MI — which companies pay providers there.
